Press Release | RPG Life Sciences
rpgls
  • Contact Us
  • Our Story
    • History and Milestones
    • Our Brand
    • Core Strengths
    • Vision, Values and Capabilities
    • Board of Directors
    • Management Team
    • Industry Awards and Recognition
  • Our Businesses
    • Business Portfolio
      • API
      • Domestic Formulations
      • International Formulations
      Manufacturing
      • Manufacturing Facilities
      • Quality
      • Environment, Health and Safety
      Scientific Overview
      • Research and Development
      • Patents
  • Therapeutic Focus
    • Nephrology
    • Rheumatology
    • Oncology
    • Urology
    • Anti-Diabetic
    • Respiratory
    • Gastroenterology
    • Cardiovascular
    • Gynaecology and Pediatrics
    • Vitamins and Minerals
    • Orthopedic
    • Neurology
    • Anti-Dengue
    • Dermatology
  • Life@RPGLS
    • Employee Connect
      Rewards and Recognition
      • Brave RPGLS Covid Warriors
      • Great Place To Work
      • Team Awards
      • Employee Awards
      Human Resources
      • Join Us
      • Company Events
      • Learning and Development
      CSR
      • Corporate Social Responsibility
      Explore Us
      Happiness Matters!!
  • Investors
    • Financial Results
      • Audited Financial Results
      • Quarterly Financial Results
      Company Presentations
      • Investor Presentations
      • Corporate Presentations
      • Earnings Call
      • Press Release
      Mandatory Disclosures
      • Code and Policies
      Shareholders Information
      • Shareholding Pattern
      • Concepts and Procedure
      • Corporate Governance Reports
      • Annual Reports
      • Intimation to Stock Exchange
      • Notices of Board Meetings
      • Outcome of Board Meetings
      • AGM & Postal Ballot
      • Unpaid Dividend List
      • TDS on Dividend Communication
      • Forms related to Physical Shares
      • Newspaper Publications
      • Market Tracker
      Investor Relations
      • Investor Education and Protection Fund
      • Investor Grievance
      • Investor Contacts
      • Investor Meets
      Committees Composition
      • Audit Committee
      • Risk Management Committee
      • Stakeholders Relationship Committee
      • Nomination & Remuneration Committee
      • SCSR Committee
      DISCLOSURES UNDER REGULATION 46 OF LODR
      • Disclosures under regulation 46 of LODR
  • Media
    • Online News and Print Media
    • RPGLS @ Industry Platforms

PRESS RELEASE
  • Home
  • press release

Sr. No. File Name (Click to Download)
1 Press realease-Q4 FY 2024-25
2 Press Release Q3 FY 2024-25
3 Press Release - SMP Appointment 2025
4 Press Release Q2 FY 2024-25
5 Press Release Q1 FY 2024 25
6 Press Release Q4 FY 2023 24
7 RPG Life Sciences Q3 FY24 press release
8 Press Release Q2 FY 2023-24
9 Press Release Q1 FY 2023-24
10 Press Release Q4 FY 2022-23
11 Press Release Q3 FY 2022-23
12 Press Release Q2 FY 2022-23
13 Press Release Q1 FY 2022-23
14 PressRelease Q4 FY 2021-22
15 Press Release - Q3 FY 2021-22
  • 1
  • 2
  • 3
  • Next

Investors Information

Annual Conference Videos
  • June 16, 2021
  • Your browser does not support HTML5 video.
Company Presentations
  • Investor Presentations
  • Corporate Presentations
  • Earnings Call
  • Press Release
Financial Results
  • Audited Financial Results
  • Quarterly Financial Results
  • Dividend Declarations
Investor Relations
  • Investor Education and Protection Fund
  • Investor Grievance
  • Investor Contacts
  • Investor Meets
Share Holders Information
  • Shareholding Pattern
  • Concepts and Procedure
  • Corporate Governance Reports
  • Annual Reports
  • Intimation to Stock Exchange
  • Notices of Board Meetings
  • Outcome of Board Meetings
  • AGM & Postal Ballot
  • Unpaid Dividend List
  • TDS on dividend communication
  • Forms related to Physical Shares
  • Reg. 46 SEBI (LODR)
  • Newspaper Publications
  • Market tracker
Board Committees
  • Audit Committee
  • Risk Management Committee
  • Stakeholders Relationship Committee
  • Nomination & Remuneration Committee
  • SCSR Committee
Mandatory Disclosures
  • Code and Policies
  • Disclosures under regulation 46 of LODR
Get in Touch

QUICK LINKS

Vision

Quality

History and Milestones

Company Awards

Manufacturing Facilities

Research and Development

Offline PDF form
Drugs Safety – Adverse Event Reporting

Contact Us

  • Address:
    RPG Life Sciences Limited,
    RPG HOUSE, 463, Dr. Annie Besant Road, Worli,
    Mumbai - 400030, India

  • Phone: 91-22-69757100

  • Fax:

  • Email:

Follow Us




Porto Website Template

RPG Life Sciences Limited © Copyright 2018-19. All Rights Reserved.

  • Privacy Policy
  • Cookie Policy
  • Terms and Conditions
  • Sitemap